Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel H Zimmerman

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cellular Immunology|February 19, 2010
Maturation of dendritic cell precursors into IL12-producing DCs by J-LEAPS immunogensPatricia R Taylor, Christopher C Paustian, Gary K Koski, et al.
Frontiers in Immunology|March 21, 2024
Current status of immunological therapies for rheumatoid arthritis with a focus on antigen-specific therapeutic vaccinesDaniel H Zimmerman, Zoltan Szekanecz, Adrienn Markovics, et al.
Biomedicines|January 21, 2022
Restoring the Balance between Pro-Inflammatory and Anti-Inflammatory Cytokines in the Treatment of Rheumatoid Arthritis: New Insights from Animal ModelsAdrienn Markovics, Ken S Rosenthal, Katalin Mikecz, et al.
Expert Review of Vaccines|March 20, 2015
Rheumatoid arthritis vaccine therapies: perspectives and lessons from therapeutic ligand epitope antigen presentation system vaccines for models of rheumatoid arthritisKenneth S Rosenthal, Katalin Mikecz, Harold L Steiner, et al.
International Immunopharmacology|January 16, 2010
CEL-2000: A therapeutic vaccine for rheumatoid arthritis arrests disease development and alters serum cytokine/chemokine patterns in the bovine collagen type II induced arthritis in the DBA mouse modelDaniel H Zimmerman, Patricia Taylor, Alison Bendele, et al.
International Immunopharmacology|April 5, 2008
L.E.A.P.S. heteroconjugate is able to prevent and treat experimental autoimmune myocarditis by altering trafficking of autoaggressive cells to the heartDaniela Cihakova, Jobert G Barin, G Christian Baldeviano, et al.
Vaccines|June 2, 2021
Vaccination by Two DerG LEAPS Conjugates Incorporating Distinct Proteoglycan (PG, Aggrecan) Epitopes Provides Therapy by Different Immune Mechanisms in a Mouse Model of Rheumatoid ArthritisDaniel H Zimmerman, Katalin Mikecz, Adrienn Markovics, et al.
Vaccine|June 7, 2017
An epitope-specific DerG-PG70 LEAPS vaccine modulates T cell responses and suppresses arthritis progression in two related murine models of rheumatoid arthritisKatalin Mikecz, Tibor T Glant, Adrienn Markovics, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2004
A small peptide (CEL-1000) derived from the beta-chain of the human major histocompatibility complex class II molecule induces complete protection against malaria in an antigen-independent mannerYupin Charoenvit, Gary T Brice, David Bacon, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cellular Immunology|February 19, 2010
Maturation of dendritic cell precursors into IL12-producing DCs by J-LEAPS immunogensPatricia R Taylor, Christopher C Paustian, Gary K Koski, et al.
Frontiers in Immunology|March 21, 2024
Current status of immunological therapies for rheumatoid arthritis with a focus on antigen-specific therapeutic vaccinesDaniel H Zimmerman, Zoltan Szekanecz, Adrienn Markovics, et al.
Biomedicines|January 21, 2022
Restoring the Balance between Pro-Inflammatory and Anti-Inflammatory Cytokines in the Treatment of Rheumatoid Arthritis: New Insights from Animal ModelsAdrienn Markovics, Ken S Rosenthal, Katalin Mikecz, et al.
Expert Review of Vaccines|March 20, 2015
Rheumatoid arthritis vaccine therapies: perspectives and lessons from therapeutic ligand epitope antigen presentation system vaccines for models of rheumatoid arthritisKenneth S Rosenthal, Katalin Mikecz, Harold L Steiner, et al.
International Immunopharmacology|January 16, 2010
CEL-2000: A therapeutic vaccine for rheumatoid arthritis arrests disease development and alters serum cytokine/chemokine patterns in the bovine collagen type II induced arthritis in the DBA mouse modelDaniel H Zimmerman, Patricia Taylor, Alison Bendele, et al.
International Immunopharmacology|April 5, 2008
L.E.A.P.S. heteroconjugate is able to prevent and treat experimental autoimmune myocarditis by altering trafficking of autoaggressive cells to the heartDaniela Cihakova, Jobert G Barin, G Christian Baldeviano, et al.
Vaccines|June 2, 2021
Vaccination by Two DerG LEAPS Conjugates Incorporating Distinct Proteoglycan (PG, Aggrecan) Epitopes Provides Therapy by Different Immune Mechanisms in a Mouse Model of Rheumatoid ArthritisDaniel H Zimmerman, Katalin Mikecz, Adrienn Markovics, et al.
Vaccine|June 7, 2017
An epitope-specific DerG-PG70 LEAPS vaccine modulates T cell responses and suppresses arthritis progression in two related murine models of rheumatoid arthritisKatalin Mikecz, Tibor T Glant, Adrienn Markovics, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2004
A small peptide (CEL-1000) derived from the beta-chain of the human major histocompatibility complex class II molecule induces complete protection against malaria in an antigen-independent mannerYupin Charoenvit, Gary T Brice, David Bacon, et al.
Pageof 2